Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.

Revenue
+3.22%
EPS
+1,855.6%
Free cash flow
−6.48%
Total debt
−1.13%

Quarter to September 2026, against a year earlier

24.98 2.21 −8.13%
Market cap
$4.0B
P/E
6.4×
Fwd P/E
21.5×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a

Envista Holdings Corporation (NVST) Shares outstanding

Alert me on Shares outstanding

Envista Holdings Corporation's shares outstanding at the end of fiscal 2025 was $169.2M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $163.4M. Over the past ten years it has ranged from $127.9M (fiscal 2018) to $177.6M (fiscal 2022); the current reading is higher than 70% of that period. Envista Holdings Corporation ranks 13th of 47 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $169.2M (1.74%)
FY2024 $172.2M 3.18%
FY2023 $166.9M (6.02%)
FY2022 $177.6M 0.00%
FY2021 $177.6M 8.23%
FY2020 $164.1M 20.31%
FY2019 $136.4M 6.65%
FY2018 $127.9M 0.00%
FY2017 $127.9M (19.56%)
FY2016 $159.0M —

Quarterly newest first

Period Shares outstanding Change
Sep 2026 $163.4M (0.43%)
Jun 2026 $164.1M (1.38%)
Mar 2026 $166.4M (1.65%)
Dec 2025 $169.2M 1.87%
28 more quarters

Against its own ten years

Low $127.9M High $177.6M
Ten-year median $165.5M
Current reading's percentile 70

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on NVST